Can a Tech-Powered home program help stroke survivors walk better?

NCT ID NCT07623018

Not yet recruiting Symptom relief Sponsor: University of Exeter Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a gait training program delivered partly at home using a sensor and exercises is feasible and acceptable for people who have had a stroke. Twelve participants in Saudi Arabia will first train in a clinic, then continue at home for four weeks. The goal is to see if they can stick with the program and if it is safe, not yet to prove it improves walking.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: STEP-Tech intervention (telerehabilitation gait training program using Heel2Toe sensor and exercises)
What this could lead to: If successful, this could show that a home-based, tech-supported gait program is practical and acceptable for stroke survivors, paving the way for larger studies to improve walking recovery.
What could go wrong: This is a very small, early feasibility study with only 12 participants, so results may not apply to all stroke survivors. It does not yet test whether the program actually improves walking.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STROKE

Contacts and locations

Show contact details

Locations

Aseer Rehabilitation Centre

Abhā, Southern Region, Saudi Arabia
Sultan Bin Abdulaziz Humanitarian City (SBAHC)

Riyadh, Saudi Arabia

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.